Serum Lactate Dehydrogenase in Non-Hodgkin’s Lymphoma: A Prognostic Indicator
暂无分享，去创建一个
[1] R. Taboła,et al. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. , 2015, Cancer letters.
[2] B. Humphreys,et al. Onco-nephrology: AKI in the cancer patient. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[3] P. Zinzani. Lymphoma: diagnosis, staging, natural history, and treatment strategies. , 2005, Seminars in oncology.
[4] D. Steensma,et al. Elevated serum LDH in patients with non‐Hodgkin's lymphoma: not always an ominous sign , 1999, British journal of haematology.
[5] M. Engelhard,et al. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. , 1997, Blood.
[6] J. Radford,et al. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma. , 1989, British Journal of Cancer.
[7] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[8] M. Vidyasagar,et al. Non-Hodgkin's lymphoma: is India ready to incorporate recent advances in day to day practice? , 2010, Journal of cancer research and therapeutics.
[9] S. Pileri,et al. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features. , 1984, Acta haematologica.